Reuters logo
BUZZ-Heron Therapeutics: FDA approves chemotherapy-induced nausea drug
November 9, 2017 / 10:12 PM / a month ago

BUZZ-Heron Therapeutics: FDA approves chemotherapy-induced nausea drug

** Drug developer’s shares rise 4.9 pct to $18.20 after market

** Company says FDA approved its drug to prevent chemotherapy-induced nausea (CINV) in adults

** The intravenous drug, Cinvanti, will be used in combination with other agents to prevent delayed nausea and vomiting associated with some forms of chemotherapy; Expects launch in Jan 2018

** CINV is one of the most acute side effects of cancer therapy and affects up to 80 pct of patients, according to the National Institute of Health

** Up to Thursday’s close, stock had risen 8.1 pct YTD (Reporting by Divya Grover)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below